The Company Behind the COVID-Killing Pill Only Stands to Profit
Shah Gilani|December 3, 2021
Big pharma has cooked up yet another fantastic biotech company for us investors.
Not only does this company pay an incredible dividend – it has a 30% profit margin. That’s unheard of for a company of this size in this industry.
So, let’s get in today.
Click the video below to grab this stock and three other picks.
[bc_video video_id=”6284886142001″ account_id=”4250799609001″ player_id=”hpkprVYKS6″ embed=”in-page” padding_top=”56%” autoplay=”” min_width=”0px” max_width=”640px” mute=”” width=”100%” height=”100%” ]
Now, before you check out for the weekend I want to give you a heads up. I’ve got another special report on its way to your inbox right now.
J. Powell and the Fed were once again chanting their “transitory” inflation mantra – what a joke.
At 12:00pm EST, you can expect my response to their claims and one more pick before the markets close for the weekend. Be on the lookout.
See you then,
Shah
Shah Gilani
Shah Gilani is the Chief Investment Strategist of Manward Press. Shah is a sought-after market commentator… a former hedge fund manager… and a veteran of the Chicago Board of Options Exchange. He ran the futures and options division at the largest retail bank in Britain… and called the implosion of U.S. financial markets (AND the mega bull run that followed). Now at the helm of Manward, Shah is focused tightly on one goal: To do his part to make subscribers wealthier, happier and more free.